Saluda Medical Pty Ltd

Saluda Medical is a global neuromodulation company headquartered in Bloomington, Minnesota, specializing in advanced spinal cord stimulation (SCS) therapies for chronic pain management. The company's flagship product, the Evoke® System, is the first FDA-indicated closed-loop SCS system that directly senses and measures the spinal cord's physiologic response using Evoked Compound Action Potentials (ECAPs), enabling real-time adjustment of stimulation parameters for optimal therapeutic efficacy. Founded in 2011, Saluda Medical has developed over 15 years of research and clinical experience, with published clinical evidence demonstrating long-term pain relief outcomes extending to 36 months. The company operates across North America, Australia, the United Kingdom, and the Netherlands, serving clinicians and patients seeking alternatives to opioid-based pain management for chronic intractable pain conditions affecting over 540 million people globally.